Funding
← Back to your selection

Pfizer Ventures

Activity from announced rounds

Activity in this selectionOct 6, 2026 · AI · Jan 1, 2026

Pfizer Ventures is the venture unit whose official portfolio includes TRIMTECH and TwoStep and whose partner Rana Al-Hallaq is identified in company materials.

Recorded funding activity

TwoStep develops targeted cancer therapies. TRIMTECH develops protein-degrading medicines for neurological disease, while Crossbow develops cancer antibodies. These relationships remain distinct from generic Pfizer corporate participation.

Sources
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$101.2M
2 disclosed · full round size, not this investor’s share

By stage

Seed1
Series B1

By primary sector

Biotech2

By country

France1
United States1

Rounds

2 in this selection
Enodia Therapeutics

Develops small-molecule therapies for targeted protein degradation at the point of synthesis

Role not disclosed